Answers are grounded in this paper and cite their sources.
This study examines which antigen transcripts persist in portal-vein tumour thrombus (PVTT) and lymph-node metastases of hepatocellular carcinoma (HCC), and develops hypotheses about the molecular programmes that sustain established lesions. PVTT and nodal metastasis were analysed separately against their corresponding primary tumours using public single-cell and bulk RNA datasets. The study includes two single-cell primary-PVTT pairs, one primary-node pair and an external primary tumour with two nodes provisionally linked to one patient. Two bulk cohorts contributed 19 and 11 primary-PVTT pairs. Vascular involvement was also examined in 157 CHCC-HBV and 293 TCGA-LIHC primary tumours. At a common depth of 3,000 UMI, both thrombi retained GPC3 and MAGEA4 RNA, and PGF detection was higher in each thrombus than in its matched primary. In paired tissue, 24 of 30 thrombi retained their primary tumour's hepatic-proliferative class, and 23 of 30 had higher ESM1 RNA. Both cohorts showed lower DCN RNA in thrombi than in matched primary tumours. Single-cell profiles localized ESM1 chiefly to endothelium. In both primary-tumour cohorts, vascular involvement accompanied higher proliferative-minus-hepatic scores and lower Hoshida S3 similarity. In CHCC-HBV, the association of the proliferative-side class with recorded thrombus attenuated after adjustment for Hoshida class, tumour size and number. In one nodal case, depth-matched expected detection within a shared tumour-cell state fell from 61.6% to 0.9% for MAGEA4 and from 22.7% to 0.5% for PRAME. MAGEA3 remained detectable across the broader nodal tumour-cell population. The external primary already lacked detectable MAGEA4 and PRAME RNA, precluding assessment of their nodal loss. All three nodes showed lower GPC3 and higher MUC1, TGFA and CA9 RNA than their corresponding primaries. These findings support lesion-specific antigen assessment. Supplementary Notes and network maps develop a PVTT maintenance hypothesis involving reduced decorin-associated restraint and ESM1-associated growth-factor support, and a nodal maintenance hypothesis in which the contribution of MUC1-EGFR signalling, TGFA and CA9 varies with epithelial state. The record contains the manuscript, supplementary methods and results, independent Supplementary Notes with separate references, supplementary tables, figure images and derived source data. Figures S11-S14 also appear at the end of the main manuscript. The source archive includes gene-effect tables, specimen-level summaries, input ledgers, cohort rosters and figure/table source data with checksums. Analysis and drawing scripts are available from the author on request. The companion study of HCC tumour-epithelial states is available at https://doi.org/10.5281/zenodo.24298256. The manuscript and original contributions are shared under Creative Commons Attribution 4.0 International (CC BY 4.0). Third-party data and annotations retain their original licences and repository terms.
No takes yet. Share an insight, caveat, or question.
Young Min Park (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: